Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 11Not yet recruiting 4Completed 2Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Sleep Wake Disorders 1Hematologic Neoplasms 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1

Interventions

pembrolizumab 70Cyclophosphamide 46Cisplatin 42Nivolumab 33Radiotherapy 30Paclitaxel 30Gemcitabine 30Carboplatin 28Docetaxel 26Dexamethasone 22atezolizumab 20Blood Specimen Collection 20Bevacizumab 19Rituximab 18Radiosurgery 18Fluorouracil 18fludarabine 17Magnetic Resonance Spectroscopy 17Leucovorin 17Lenalidomide 17Surveys and Questionnaires 16Oxaliplatin 16Doxorubicin 15Irinotecan 14Etoposide 14palbociclib 13Vincristine 13Radiotherapy, Intensity-Modulated 13Prednisone 13Letrozole 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Exercise Test × 90 days × Clear all
NCT00819208 2026-04-24

CHALLENGE

Canadian Cancer Trials Group

Phase NA Completed
889 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT05106374 2026-04-13

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Completed
182 enrolled
Other hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡